Assessing the origin of high-grade serous ovarian cancer using CRISPR-modification of mouse organoidsKadi Lõhmussaar, Hans Clevers|Nature Communications|2020Cited by 120
Organoid technology as an emerging tool for gynecological oncology researchKadi Lõhmussaar|Unknown|2020Cited by 0